NL-OMON45884已完成3 期
Open-label, Interventional, Cohort Study to Evaluate Long-term Safety of Dupilumab in Patients with Moderate to Severe Asthma who Completed the TRAVERSE-LTS12551Clinical Trial - LONG-TERM FOLLOW-UP (LTFU Traverse)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Patients with asthma who completed the treatment period in the previous dupilumab asthma clinical study LTS12551.;-Signed written informed consent.
排除标准
- •Patients who experienced any systemic hypersensitivity reactions to the IMP in the previous dupilumab asthma study, which, in the opinion of the Investigator, could indicate that continued treatment with dupilumab may present an unreasonable risk for the patient.
研究者
相似试验
进行中（未招募）
1 期
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety inPatients with Asthma (Long-Term Follow-Up)MedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2017-002134-23-Outside-EU/EEASanofi-aventis groupe
进行中（未招募）
1 期
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients with Asthma (Long-Term Follow-Up)AsthmaEUCTR2017-002134-23-BEsanofi-aventis groupe750
进行中（未招募）
1 期
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients with Asthma (Long-Term Follow-Up)MedDRA version: 20.0 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2017-002134-23-FRsanofi-aventis groupe750
进行中（未招募）
1 期
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients with Asthma (TRAVERSE CONTINUATION)MedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2017-002134-23-NLsanofi-aventis groupe750
进行中（未招募）
1 期
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients with Asthma (Long-Term Follow-Up)MedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2017-002134-23-DEsanofi-aventis groupe750